The goal of this trial is to see whether a test based on a new technology which assesses tumor cell mass accumulation rate (MAR) can help to predict how patients with relapsed/refractory disease will respond to multiple myeloma treatments.
This trial is currently open and accepting patients.
Researchers are asking patients who participate in this clinical trial to provide an approximately 10mL (2 teaspoons) bone marrow sample. This sample will be collected at a time when a bone marrow biopsy is already being performed as part of your standard of care treatment and will not require an additional procedure. This study has two groups, also called cohorts. Each cohort will provide the same volume of a one-time bone marrow sample.
Researchers are also requesting access to your medical information and myeloma treatment history. This data will be de-identified, and securely stored.
If you agree to take part in this study, there will be no direct medical benefit or additional costs to you.
You and your physician will not be informed of the results of the tests on your tumor cells at the time your physician is deciding on your treatment as the accuracy of this test is not yet proven. Proving the value of this this test is the purpose of this study. The testingprocedure is not a treatment. There is no benefit to participating in this part of the study except for the satisfaction of contributing to scientific knowledge. We hope the information learned from this study will benefit other people with multiple myeloma in the future.
The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.
Observational Trial
Enrollment: 130 patients (estimated)
View MoreRead the latest news and updates on this trial.
October 23, 2019
Can you tell how well a myeloma treatment might work on your personal tumor by weighing the cancer cells? Clifford Reid, PhD and CEO of Travera shares a new approach to “personalized medicine” in multiple myeloma.
View all clinical trial locations sorted by state.
We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.
(888) 828-2206If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.
You can explore trial locations from around the US and connect directly with a trial coordinator.
Find Nearby LocationsYou can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.
Still need help? Send us a message
SparkCures is working closely with Travera LLC to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.
Learn more about how we work with trial sponsors